EyeControl: A Communication Solution for Ventilated ICU Patients and Locked-in Individuals
- Funded by European Commission
- Total publications:0 publications
Grant number: 961050
Grant search
Key facts
Disease
COVID-19Start & end year
20202022Known Financial Commitments (USD)
$2,518,897.62Funder
European CommissionPrincipal Investigator
RETZKIN OrResearch Location
IsraelLead Research Institution
EYEFREE ASSISTING COMMUNICATION LTDResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Supportive care, processes of care and managementSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
UnspecifiedBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
EyeFree Assisting Communication Ltd. developed the EyeControl, the first wearable, screenless assistive communication device. AI-powered eye-tracking technology enables communication between patients, medical staff and family, using only eye movements, without calibration or dependency on a screen or computer. EyeFree is changing reality, empowering autonomy among the Locked-in community by providing a round-the-clock communication solution that is operated independently by the user. EyeFree is expanding the scope of the recently finalized SME Phase 2 grant with the aim of developing additional improvements to the EyeControl technology, which will expedite medical facility market entry strategy. Short-term demand in this segment is growing; where an unmet need for communication in the ICU already existed, it has been further exasperated by an influx of ventilation caused by the Coronavirus. There is no solution on the market; and, that places the EyeControl at the forefront, as an immediate and effective assistive technology, facilitating easy and safe communication between patients, medical staff, caregivers, and families and leading to better quality patient care. Once this niche market has been consolidated, we will boost the market entry be known as the global communication platform for both ventilated and Locked-in patients, with two main product lines: EyeControl Home and Facility.